Psoralen and Bergapten: In Silico Metabolism and Toxicophoric Analysis of Drugs Used to Treat Vitiligo

PURPOSE: to discuss the contribution of psoralen and bergapten metabolites on psoralens toxicity. METHODS: Computational chemistry prediction of metabolic reactions and toxicophoric groups based on the expert systems Derek and Meteor. RESULTS: a total of 15 metabolites were suggested for both psoral...

Full description

Bibliographic Details
Main Authors: Vinicius Barreto da Silva, Daniel Fábio Kawano, Ivone Carvalho, Edemilson Cardoso Conceição, Osvaldo Freitas, Carlos Henrique Tomich de Paula Silva
Format: Article
Language:English
Published: Frontiers Media S.A. 2009-12-01
Series:Journal of Pharmacy & Pharmaceutical Sciences
Online Access:https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/6499
_version_ 1797709191069040640
author Vinicius Barreto da Silva
Daniel Fábio Kawano
Ivone Carvalho
Edemilson Cardoso Conceição
Osvaldo Freitas
Carlos Henrique Tomich de Paula Silva
author_facet Vinicius Barreto da Silva
Daniel Fábio Kawano
Ivone Carvalho
Edemilson Cardoso Conceição
Osvaldo Freitas
Carlos Henrique Tomich de Paula Silva
author_sort Vinicius Barreto da Silva
collection DOAJ
description PURPOSE: to discuss the contribution of psoralen and bergapten metabolites on psoralens toxicity. METHODS: Computational chemistry prediction of metabolic reactions and toxicophoric groups based on the expert systems Derek and Meteor. RESULTS: a total of 15 metabolites were suggested for both psoralen and bergapten based on phase 1 and 2 biotransformations until the 3rd generation. Five toxicophoric substructures were shared among psoralen, bergapten and their corresponding metabolites; one toxicophoric marker (resorcinol) was only identified in bergapten and its biotransformation products. CONCLUSION: Although the toxic effects of psoralens are well known and documented, there is little information concerning the role of their metabolites in this process. We believe this work add to the knowledge of which molecular substructures are relevant to the process of metabolism and toxicity induction, thus guiding the search and development of more effective and less toxic drugs to treat vitiligo.
first_indexed 2024-03-12T06:32:46Z
format Article
id doaj.art-30fdc7b74e944b55af52691b40275d89
institution Directory Open Access Journal
issn 1482-1826
language English
last_indexed 2024-03-12T06:32:46Z
publishDate 2009-12-01
publisher Frontiers Media S.A.
record_format Article
series Journal of Pharmacy & Pharmaceutical Sciences
spelling doaj.art-30fdc7b74e944b55af52691b40275d892023-09-03T01:29:49ZengFrontiers Media S.A.Journal of Pharmacy & Pharmaceutical Sciences1482-18262009-12-0112310.18433/J3W01DPsoralen and Bergapten: In Silico Metabolism and Toxicophoric Analysis of Drugs Used to Treat VitiligoVinicius Barreto da Silva0Daniel Fábio Kawano1Ivone Carvalho2Edemilson Cardoso Conceição3Osvaldo Freitas4Carlos Henrique Tomich de Paula Silva5Departamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São PauloDepartamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São PauloDepartamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São PauloDepartamento de Tecnologia Farmacêutica, Faculdade de Farmácia, Universidade Federal de GoiásDepartamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São PauloDepartamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São PauloPURPOSE: to discuss the contribution of psoralen and bergapten metabolites on psoralens toxicity. METHODS: Computational chemistry prediction of metabolic reactions and toxicophoric groups based on the expert systems Derek and Meteor. RESULTS: a total of 15 metabolites were suggested for both psoralen and bergapten based on phase 1 and 2 biotransformations until the 3rd generation. Five toxicophoric substructures were shared among psoralen, bergapten and their corresponding metabolites; one toxicophoric marker (resorcinol) was only identified in bergapten and its biotransformation products. CONCLUSION: Although the toxic effects of psoralens are well known and documented, there is little information concerning the role of their metabolites in this process. We believe this work add to the knowledge of which molecular substructures are relevant to the process of metabolism and toxicity induction, thus guiding the search and development of more effective and less toxic drugs to treat vitiligo.https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/6499
spellingShingle Vinicius Barreto da Silva
Daniel Fábio Kawano
Ivone Carvalho
Edemilson Cardoso Conceição
Osvaldo Freitas
Carlos Henrique Tomich de Paula Silva
Psoralen and Bergapten: In Silico Metabolism and Toxicophoric Analysis of Drugs Used to Treat Vitiligo
Journal of Pharmacy & Pharmaceutical Sciences
title Psoralen and Bergapten: In Silico Metabolism and Toxicophoric Analysis of Drugs Used to Treat Vitiligo
title_full Psoralen and Bergapten: In Silico Metabolism and Toxicophoric Analysis of Drugs Used to Treat Vitiligo
title_fullStr Psoralen and Bergapten: In Silico Metabolism and Toxicophoric Analysis of Drugs Used to Treat Vitiligo
title_full_unstemmed Psoralen and Bergapten: In Silico Metabolism and Toxicophoric Analysis of Drugs Used to Treat Vitiligo
title_short Psoralen and Bergapten: In Silico Metabolism and Toxicophoric Analysis of Drugs Used to Treat Vitiligo
title_sort psoralen and bergapten in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo
url https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/6499
work_keys_str_mv AT viniciusbarretodasilva psoralenandbergapteninsilicometabolismandtoxicophoricanalysisofdrugsusedtotreatvitiligo
AT danielfabiokawano psoralenandbergapteninsilicometabolismandtoxicophoricanalysisofdrugsusedtotreatvitiligo
AT ivonecarvalho psoralenandbergapteninsilicometabolismandtoxicophoricanalysisofdrugsusedtotreatvitiligo
AT edemilsoncardosoconceicao psoralenandbergapteninsilicometabolismandtoxicophoricanalysisofdrugsusedtotreatvitiligo
AT osvaldofreitas psoralenandbergapteninsilicometabolismandtoxicophoricanalysisofdrugsusedtotreatvitiligo
AT carloshenriquetomichdepaulasilva psoralenandbergapteninsilicometabolismandtoxicophoricanalysisofdrugsusedtotreatvitiligo